A hallmark of the CWRU/UHC research enterprise is a strong emphasis on international biomedical research with a particular interest in developing countries. The sixteen-year collaboration with Ugandan government and research facilities has fostered seminal studies of TB and HIV/AIDS. A major limitation to new initiatives in the developing world is the lack of state-of-the-art laboratory facilities on site. The longstanding research relationship between CWRU, the government of Uganda and Makerare University has resulted in the development of an extensive research infrastructure in Uganda. To facilitate sharing of these resources and to promote/support new research initiatives, all laboratory facilities and services associated with HIV/AIDS research are now being administered by the CWRU/UHC CFAR Uganda Laboratory Core with the following objectives: 1. provide comprehensive laboratory services to facilitate HIV/AIDS-related research projects of CFAR investigators 2. advertise these services, process requests, and coordinate research-based assays through the Uganda Laboratory Core 3. provide a mechanism for training of Ugandan scientists in collaboration with CWRU and Fogarty AIDS Training Grant Moving forward, the Ugandan Laboratory Core seeks to: 1. develop new assays to meet the needs of the CFAR investigators and improve the quality of HIV/AIDS research in Uganda 2. continue to engage Ugandan scientists/clinicians in research collaboration with CFAR members by promoting training scholarships, sponsoring workshops and meetings

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036219-15
Application #
7636808
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
15
Fiscal Year
2008
Total Cost
$238,342
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Oliveira, Vitor H F; Perazzo, Joseph D; Josephson, Richard A et al. (2018) Association Between the 6-Minute Walk Test Distance and Peak Cardiorespiratory Fitness Among People Living with HIV Varies by Fitness Level. J Assoc Nurses AIDS Care 29:775-781
Paparisto, Ermela; Woods, Matthew W; Coleman, Macon D et al. (2018) Evolution-Guided Structural and Functional Analyses of the HERC Family Reveal an Ancient Marine Origin and Determinants of Antiviral Activity. J Virol 92:
Llewellyn, George N; Alvarez-Carbonell, David; Chateau, Morgan et al. (2018) HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency. J Neurovirol 24:192-203
Longenecker, Chris T; Sullivan, Claire E; Morrison, Justin et al. (2018) The effects of HIV and smoking on aortic and splenic inflammation. AIDS 32:89-94
Tomas, Myreen E; Mana, Thriveen S C; Wilson, Brigid M et al. (2018) Tapering Courses of Oral Vancomycin Induce Persistent Disruption of the Microbiota That Provide Colonization Resistance to Clostridium difficile and Vancomycin-Resistant Enterococci in Mice. Antimicrob Agents Chemother 62:
Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504
Sahmoudi, Karima; Abbassi, Hassan; Bouklata, Nada et al. (2018) Immune activation and regulatory T cells in Mycobacterium tuberculosis infected lymph nodes. BMC Immunol 19:33
Webel, Allison R; Moore, Shirley M; Longenecker, Chris T et al. (2018) Randomized Controlled Trial of the SystemCHANGE Intervention on Behaviors Related to Cardiovascular Risk in HIV+ Adults. J Acquir Immune Defic Syndr 78:23-33
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Eckard, Allison Ross; O'Riordan, Mary Ann; Rosebush, Julia C et al. (2018) Vitamin D supplementation decreases immune activation and exhaustion in HIV-1-infected youth. Antivir Ther 23:315-324

Showing the most recent 10 out of 539 publications